Project Details
Description
Phase 1/2 Study of IDP-023 as a Single Agent and in Combination with Antibody Therapies in Patients with Advanced Hematologic Cancers
| Status | Active |
|---|---|
| Effective start/end date | 7/25/23 → 7/31/33 |
Funding
- INDAPTA THERAPEUTICS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.